Literature DB >> 12037212

Properties of nicotinic receptors underlying Renshaw cell excitation by alpha-motor neurons in neonatal rat spinal cord.

Michelle Dourado1, Peter B Sargent.   

Abstract

We used anatomical and physiological approaches to characterize nicotinic receptors (AChRs) on Renshaw cells of the neonatal rat spinal cord. Confocal imaging of Renshaw cells, identified by their characteristic pattern of gephyrin immunoreactivity, revealed that these neurons are immuno-positive for the alpha4 and beta2 AChR subunits but not for the alpha7 subunit. We used whole cell recording in spinal cord slices to characterize synaptic transmission from alpha-motor neurons to Renshaw cells, which could be identified pharmacologically by the sensitivity of transmission to d-tubocurarine. alpha-Motor neuron-to-Renshaw cell synapses were blocked by 10 microM dihydro-beta-erythroidine (dHbetaE), but not 50 nM methyllycaconitine (MLA), a selective alpha7 antagonist. These findings support a role for alpha4beta2-like AChRs, but not alpha7 AChRs, in rapid excitatory transmission between alpha-motor neurons and Renshaw cells in rat spinal cord.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037212     DOI: 10.1152/jn.2002.87.6.3117

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  13 in total

1.  Activation of group I metabotropic glutamate receptors depresses recurrent inhibition of motoneurons in the neonatal rat spinal cord in vitro.

Authors:  Cristina Marchetti; Giuliano Taccola; Andrea Nistri
Journal:  Exp Brain Res       Date:  2005-07-01       Impact factor: 1.972

Review 2.  The continuing case for the Renshaw cell.

Authors:  Francisco J Alvarez; Robert E W Fyffe
Journal:  J Physiol       Date:  2007-07-19       Impact factor: 5.182

3.  The Preparation of Oblique Spinal Cord Slices for Ventral Root Stimulation.

Authors:  Félix Leroy; Boris Lamotte d'Incamps
Journal:  J Vis Exp       Date:  2016-10-13       Impact factor: 1.355

Review 4.  High affinity and low affinity heteromeric nicotinic acetylcholine receptors at central synapses.

Authors:  Boris Lamotte d'Incamps; Philippe Ascher
Journal:  J Physiol       Date:  2014-05-16       Impact factor: 5.182

5.  Noncholinergic excitatory actions of motoneurons in the neonatal mammalian spinal cord.

Authors:  George Z Mentis; Francisco J Alvarez; Agnes Bonnot; Dannette S Richards; David Gonzalez-Forero; Ricardo Zerda; Michael J O'Donovan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

6.  Mutant human β4 subunit identified in amyotrophic lateral sclerosis patients impairs nicotinic receptor function.

Authors:  Claudia Moriconi; Silvia Di Angelantonio; Alessio Piccioni; Flavia Trettel; Mario Sabatelli; Francesca Grassi
Journal:  Pflugers Arch       Date:  2010-11-25       Impact factor: 3.657

7.  Modulation of inhibitory strength and kinetics facilitates regulation of persistent inward currents and motoneuron excitability following spinal cord injury.

Authors:  Sharmila Venugopal; Thomas M Hamm; Sharon M Crook; Ranu Jung
Journal:  J Neurophysiol       Date:  2011-07-20       Impact factor: 2.714

8.  Functional expression of α7-nicotinic acetylcholine receptors by muscle afferent neurons.

Authors:  James C Baxter; Renuka Ramachandra; Dustin R Mayne; Keith S Elmslie
Journal:  J Neurophysiol       Date:  2014-06-25       Impact factor: 2.714

9.  Pax6 and engrailed 1 regulate two distinct aspects of renshaw cell development.

Authors:  Tamar Sapir; Eric J Geiman; Zhi Wang; Tomoko Velasquez; Sachiko Mitsui; Yoshihiro Yoshihara; Eric Frank; Francisco J Alvarez; Martyn Goulding
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

10.  Cholinergic terminals in the ventral horn of adult rat and cat: evidence that glutamate is a cotransmitter at putative interneuron synapses but not at central synapses of motoneurons.

Authors:  T T Liu; B A Bannatyne; E Jankowska; D J Maxwell
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.